Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 3 Insider Initial Statement of Ownership
  4. CT ORDER Other Confidential Order
  5. 4 Open-market sale Chief Financial Officer sold 2,500 shares at $50.00 ($125,000)
  6. 4 Derivatives Options or other derivatives
  7. 4 Grant or award EVP, Chief Scientific Officer acquired 32,701 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 8-K Event Shareholder vote results
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. DEFA14A Proxy Proxy Materials
  16. 8-K Event Material agreement
  17. 424B5 Offering Prospectus
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations
  20. DEFA14A Proxy Proxy Materials

Page 17 of 37 · 731 filings